Noxxon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Noxxon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Noxxon Today - Breaking & Trending Today

TME Pharma N.V.: NOXXON Pharma Announces Name Change to TME Pharma and New Trading Symbol

Regulatory News: TME Pharma N.V., a biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), announced todayit has officially ....

United States , Arthur Rouill , Bryan Jennings , Aram Mangasarian , Merck Keytruda , Guillaume Van Renterghem , Merck Sharp Dohme Corp , Regulatory News , Euronext Growth Paris , Merck Sharp Dohme , Media Relations ,

NOXXON Pharma N.V.: NOXXON Announces Changes to Its Supervisory Board

Regulatory News: NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX) (Paris:ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME) ....

France General , Arthur Rouill , Aram Mangasarian , Pharmanv Euronext , Merck Keytruda , Guillaume Van Renterghem , Maurizio Petitbon , Merck Sharp Dohme Corp , Regulatory News , Euronext Growth Paris , Gregory Weaver , Supervisory Board , Chief Financial Officer , Merck Sharp Dohme , Executive Officer , Media Relations ,

NOXXON Pharma N.V.: Half-yearly Report on the Liquidity Contract With Invest Securities

Regulatory News: NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX) (Paris:ALNOX),a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced ....

France General , Arthur Rouill , Aram Mangasarian , Pharmanv Euronext , Merck Keytruda , Guillaume Van Renterghem , Merck Sharp Dohme Corp , Regulatory News , Euronext Growth Paris , Invest Securities , Merck Sharp Dohme , Executive Officer , Media Relations ,

NOXXON Pharma N.V.: Noxxon Provides Results of Its 2022 Annual General Meeting of Shareholders

Noxxon Pharma to Become "TME Pharma" Regulatory News: NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX) (Paris:ALNOX), a biotechnology company focused on improving cancer treatments by targeting ....

France General , Guillaume Van Renterghem , Arthur Rouill , Aram Mangasarian , Bryan Jennings , Pharmanv Euronext , Merck Keytruda , Cornelis Alexander Izeboud , Maurizio Petitbon , Merck Sharp Dohme Corp , Noxxon Pharma , Euronext Growth Paris , Euronext Growth , Baker Tilly , Merck Sharp Dohme , Executive Officer , Media Relations ,

NOXXON Pharma N.V: NOXXON Announces Corporate Action to Start the Parity Period

Regulatory News: NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX) (Paris:ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME) ....

France General , Arthur Rouill , Aram Mangasarian , Pharmanv Euronext , Merck Keytruda , Guillaume Van Renterghem , Merck Sharp Dohme Corp , Regulatory News , Euronext Growth Paris , Merck Sharp Dohme , Executive Officer , Media Relations ,